Zobrazeno 1 - 10
of 341
pro vyhledávání: '"Puar P"'
Autor:
William Barbour, Erika Wolff, Pankaj Puar, Makoto Hibino, Ehab Bakbak, Aishwarya Krishnaraj, Raj Verma, Meena Verma, Adrian Quan, Andrew T. Yan, Kim A. Connelly, Hwee Teoh, C. David Mazer, Subodh Verma
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background This exploratory sub-analysis of the EMPA-HEART CardioLink-6 trial examined whether the previously reported benefit of the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin on left ventricular (LV) mass (LVM) regressi
Externí odkaz:
https://doaj.org/article/098a1e7724b54b69ab9de1d8e4f93108
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 23 (2023)
BACKGROUND Elevated blood pressure (BP) is associated with increased risk of cardiovascular mortality. However, there is ongoing debate whether intensive BP lowering may paradoxically increase the risk of cardiovascular disease (CVD), especially in p
Externí odkaz:
https://doaj.org/article/93485aa89820431d8719a28ae7eacd45
Autor:
Pankaj Puar, Makoto Hibino, C. David Mazer, Andrew T. Yan, Arjun K. Pandey, Adrian Quan, Hwee Teoh, David A. Hess, Raj Verma, Kim A. Connelly, Subodh Verma
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-8 (2023)
Abstract Background The cardiovascular (CV) benefits of sodium-glucose transport protein 2 inhibitors have been attributed, in part, to cardiac reverse remodelling. The EMPA-HEART CardioLink-6 study reported that sodium-glucose cotransporter-2 inhibi
Externí odkaz:
https://doaj.org/article/ab616f36e927471c96ec9a99369e168c
Autor:
Raj Verma, Michael Moroney, Makoto Hibino, Cyril David Mazer, Kim A. Connelly, Andrew T. Yan, Adrian Quan, Hwee Teoh, Subodh Verma, Pankaj Puar
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 2127-2133 (2023)
Abstract Aims The neutrophil‐to‐lymphocyte ratio (NLR) is a marker of systemic inflammation and plays a critical role in the assessment and prognosis in patients with heart failure. The EMPA‐HEART CardioLink‐6 trial demonstrated that patients
Externí odkaz:
https://doaj.org/article/64267abfe5594b0b9e61c6c2948cb34b
Autor:
Michael Moroney, Raj Verma, Makoto Hibino, C. David Mazer, Kim A. Connelly, Andrew T. Yan, Adrian Quan, Hwee Teoh, Subodh Verma, Pankaj Puar
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 2134-2140 (2023)
Abstract Aims The duration of type 2 diabetes mellitus (T2DM) is an important determinant of diabetes severity. The EMPA‐HEART CardioLink‐6 trial reported significant left ventricular (LV) mass indexed to body surface area (LVMi) regression in pa
Externí odkaz:
https://doaj.org/article/8ecb7008fdf64847b9fcb569bbb68342
Autor:
Pankaj Puar, Nikhil Mistry, Kim A. Connelly, Andrew T. Yan, Adrian Quan, Hwee Teoh, Yi Pan, Raj Verma, David A. Hess, Subodh Verma, C. David Mazer
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 2113-2119 (2023)
Abstract Aims Given recent suggestions that serum levels of insulin‐like growth factor‐binding protein 7 (IGFBP7) may identify patients who derive greater cardiorenal benefits from treatment with sodium‐glucose transport 2 inhibitors (SGLT2i),
Externí odkaz:
https://doaj.org/article/081484839763423c80793e131c87bae5
Autor:
Makoto Hibino, MD, Subodh Verma, MD, Arjun K. Pandey, BHSc, Gianluigi Bisleri, MD, Bobby Yanagawa, MD, Raj Verma, Pankaj Puar, BHSc, Adrian Quan, MPhil, Hwee Teoh, PhD, Terrence M. Yau, MD, Atul Verma, MD, Andrew C.T. Ha, MD, C. David Mazer, MD
Publikováno v:
CJC Open, Vol 5, Iss 4, Pp 285-291 (2023)
Background: Whether statins reliably reduce the risk of postoperative atrial fibrillation (POAF) in patients undergoing cardiac surgery remains controversial. We sought to determine the impact of statin use on new-onset postdischarge POAF in the Post
Externí odkaz:
https://doaj.org/article/fc1e856fb37e4eccbe995e66e1ee7eee
Autor:
Fionn Chua, Audrey Lam, Ying Hui Mak, Zhong Hui Lee, Lily Mae Dacay, Jie Lin Yew, Troy Puar, Joan Khoo, Weien Chow, Vern Hsen Tan, Khim Leng Tong, Boon Wah Liew, Colin Yeo, Wann Jia Loh
Publikováno v:
Frontiers in Epidemiology, Vol 3 (2023)
ObjectivesThis study aims to investigate the prevalence of undiagnosed cardiovascular risk factors in patients with ischaemic heart disease (IHD).MethodsWe assessed the prevalence of previously undiagnosed cardiovascular risk factors, including eleva
Externí odkaz:
https://doaj.org/article/5c2e7294757a40599a40bed47911e074
Autor:
Akshan Puar, MBBS, Diane Donegan, MD, Paul Helft, MD, Matthew Kuhar, MD, Jonathan Webster, MD, Megana Rao, BS, Michael Econs, MD
Publikováno v:
AACE Clinical Case Reports, Vol 8, Iss 5, Pp 217-220 (2022)
Background/Objective: Pemigatinib, a fibroblast growth factor receptor (FGFR) 1-3 inhibitor, is a novel therapeutic approach for treating cholangiocarcinoma when an FGFR fusion or gene rearrangement is identified. Although the most reported side effe
Externí odkaz:
https://doaj.org/article/fdb3b691829b4608be1a6b6a91462fd5
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Acute adrenal crisis classically presents with vomiting, altered sensorium, and hypotension. We describe a unique case manifesting with severe hypercalcemia. Addisonian crisis was unusually precipitated by fluconazole use. We reviewed other reported
Externí odkaz:
https://doaj.org/article/4bcfcdedf5b54973b870c0924b095344